BioIQ Announces The First Unified Solution For Configuring And Managing Population Health Testing Programs Post author:Sam Post published:July 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Reckitt CEO's $17B Predicament December 26, 2017 Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017 Calithera Biosciences Appoints To Board Of Directors September 21, 2017
Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017